Sofinnova Partners SAS reported a 2.7% stake in Quince Therapeutics QNCX · 1,197,711 sh · amendment · passive holder

Trade details

Type: 5% stake report
Report: 13G passive · amendment
Stake: 2.7%
Last report: 5.4% · filed 25/02/14
Shares held: 1,197,711 sh
Class: Common Stock, par value $0.001 per share
Stock: Quince Therapeutics QNCX
Holder: Sofinnova Partners SAS
Event date: 25/03/31
Filed: 25/04/30

2.7% stake · below 5%

Stake: 2.7%
Last report: 5.4%
Since last report: −2.7pp

Quince Therapeutics trades, last 26 weeks

What else happened in Quince Therapeutics around then

Filed or reported within 30 days of the trade day · 25/03/01~25/04/30

Sofinnova Partners SAS's other 5% stake reports

Sofinnova Partners SAS
5% stakeQuince Therapeutics
5% stake
Quince Therapeutics
QNCX
5.4% stake
2,397,711 sh
5.4% stake
Filed 25/02/14

Sofinnova Partners SAS reported a 2.7% stake in Quince Therapeutics QNCX · 1,197,711 sh · amendment · passive holder | Whalegun